Shares of Bristol Myers Squibb Co. BMY rose 3.67% to $57.88 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA rising 0.08% to 43,461.21 and the S&P 500 Index SPX falling 0.50% to 5,983.25. This was the stock's fifth consecutive day of gains.

We recently published a list of 10 Stocks Grow Firmer Despite Mixed Market Sentiment. In this article, we are going to take a look at where Bristol-Myers Squibb Co (NYSE:BMY) stands against other stocks that grow firmer despite mixed market sentiment.

Bristol-Myers Squibb released financial results for Q4 2024. Check out why I am upgrading BMY stock's rating from 'Buy' to 'Strong Buy'.

Sandra Leung began her legal career prosecuting homicides, a formative experience that she once said taught her "to make decisions quickly and to be accountable for those decisions."

A weekly summary of insider trading highlighting a few notable buying and selling by investors, directors and executives. The trades have taken place between February 18, 2025 and February 21, 2025. • JPMorgan Chase (NYSE:JPM) disclosed a series of transactions this week.

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $50.0 and $60.0 for Bristol-Myers Squibb, spanning the last three months.